{"id":15198,"date":"2026-07-03T16:10:45","date_gmt":"2026-07-03T10:40:45","guid":{"rendered":"https:\/\/mdforlives.com\/blog\/?p=15198"},"modified":"2026-07-03T16:10:45","modified_gmt":"2026-07-03T10:40:45","slug":"biosimilars-in-practice","status":"publish","type":"post","link":"https:\/\/mdforlives.com\/blog\/biosimilars-in-practice\/","title":{"rendered":"Biosimilars in Practice: Why Use Is Rising but Trust Still Needs Work"},"content":{"rendered":"

A patient hears that their biologic is being switched to a biosimilar. The pharmacist explains that it is highly similar to the reference medicine, approved through a regulated pathway, and used to improve access. The patient pauses and asks the question that often sits beneath every biosimilar conversation:<\/span>\u00a0<\/span><\/p>\n

\u201cWill it work the same for me?\u201d<\/span>\u00a0<\/span><\/p>\n

That moment captures the real-world challenge of biosimilars today.<\/span>\u00a0<\/span><\/p>\n

Biosimilars are no longer unfamiliar in modern healthcare. They are used across oncology, immunology, inflammatory bowel disease, rheumatology, endocrinology, and other therapy areas where biologics have become central to care. Their value is clear: they can support affordability, improve access, increase competition, and help healthcare systems manage the rising cost of biologic therapy.<\/span>\u00a0<\/span><\/p>\n

But adoption is not the same as trust.<\/span>\u00a0<\/span><\/p>\n

The MDForLives draft insight shows that biosimilar use is already established. Across a global community of over 2,500 healthcare professionals, 72% report prescribing biosimilars, while only 48% report high confidence in their use. That gap is the story. Biosimilars are being used, but they are still being evaluated case by case.<\/span>\u00a0<\/span><\/p>\n

For pharmacists, this gap matters because they often sit closest to the practical realities of biosimilar use: patient reassurance, substitution rules, prescriber coordination, adherence monitoring, documentation, and safety follow-up.<\/span><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n